Jau-Yi Li

Jau-Yi Li

Auto-generated profile, based on publicly available information

Jau-Yi Li

Division of Endocrinology, Metabolism and Lipids, Department of Medicine and

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2016 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JLJau-Yi Li
Jau-Yi Li
Chassaing BenoitChassaing Benoit
Chassaing Benoit
ATAbdul Malik Tyagi
Abdul Malik Tyagi
CVChiara Vaccaro
Chiara Vaccaro
TLTao Luo
Tao Luo
RPRoberto Pacifici
Roberto Pacifici
A eubiotic microbiota influences many physiological processes in the metazoan host, including development and intestinal homeostasis. Here, we have shown that the intestinal microbiota modulates inflammatory responses caused by sex steroid deficiency, leading to trabecular bone loss. In murine models, sex steroid deficiency increased gut permeability, expanded Th17 cells, and upregulated the osteoclastogenic cytokines TNFα (TNF), RANKL, and IL-17 in the small intestine and the BM. In germ-free (GF) mice, sex steroid deficiency failed to increase osteoclastogenic cytokine production, stimulate bone resorption, and cause trabecular bone loss, demonstrating that the gut microbiota is central in sex steroid deficiency–induced trabecular bone loss. Furthermore, we demonstrated that twice-weekly treatment of sex steroid–deficient mice with the probiotics Lactobacillus rhamnosus GG (LGG) or the commercially available probiotic supplement VSL#3 reduces gut permeability, dampens intestinal and BM inflammation, and completely protects against bone loss. In contrast, supplementation with a nonprobiotic strain of E. coli or a mutant LGG was not protective. Together, these data highlight the role that the gut luminal microbiota and increased gut permeability play in triggering inflammatory pathways that are critical for inducing bone loss in sex steroid–deficient mice. Our data further suggest that probiotics that decrease gut permeability have potential as a therapeutic strategy for postmenopausal osteoporosis.

3 March 2020 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JLJau-Yi Li
Jau-Yi Li
MYMingcan Yu
Mingcan Yu
Subhashis PalSubhashis Pal
Subhashis Pal
ATAbdul Malik Tyagi
Abdul Malik Tyagi
HDHamid Dar
Hamid Dar
RPRoberto Pacifici
Roberto Pacifici
Parathyroid hormone (PTH) is a critical regulator of skeletal development that promotes both bone formation and bone resorption. Using microbiota depletion by wide-spectrum antibiotics and germ-free (GF) female mice, we showed that the microbiota was required for PTH to stimulate bone formation and increase bone mass. Microbiota depletion lowered butyrate levels, a metabolite responsible for gut-bone communication, while reestablishment of physiologic levels of butyrate restored PTH-induced anabolism. The permissive activity of butyrate was mediated by GPR43 signaling in dendritic cells and by GPR43-independent signaling in T cells. Butyrate was required for PTH to increase the number of bone marrow (BM) regulatory T cells (Tregs). Tregs stimulated production of the osteogenic Wnt ligand Wnt10b by BM CD8+ T cells, which activated Wnt-dependent bone formation. Together, these data highlight the role that butyrate produced by gut luminal microbiota plays in triggering regulatory pathways, which are critical for the anabolic action of PTH in bone.

15 February 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
MYMingcan Yu
Mingcan Yu
Subhashis PalSubhashis Pal
Subhashis Pal
CPCameron W. Paterson
Cameron W. Paterson
JLJau-Yi Li
Jau-Yi Li
ATAbdul Malik Tyagi
Abdul Malik Tyagi
RPRoberto Pacifici
Roberto Pacifici
Estrogen deficiency causes a gut microbiome–dependent expansion of BM Th17 cells and TNF-α–producing T cells. The resulting increased BM levels of IL-17a (IL-17) and TNF stimulate RANKL expression and activity, causing bone loss. However, the origin of BM Th17 cells and TNF+ T cells is unknown. Here, we show that ovariectomy (ovx) expanded intestinal Th17 cells and TNF+ T cells, increased their S1P receptor 1–mediated (S1PR1-mediated) egress from the intestine, and enhanced their subsequent influx into the BM through CXCR3- and CCL20-mediated mechanisms. Demonstrating the functional relevance of T cell trafficking, blockade of Th17 cell and TNF+ T cell egress from the gut or their influx into the BM prevented ovx-induced bone loss. Therefore, intestinal T cells are a proximal target of sex steroid deficiency relevant for bone loss. Blockade of intestinal T cell migration may represent a therapeutic strategy for the treatment of postmenopausal bone loss.